MEGNESIUM OXIDE

MEGNESIUM OXIDE was reported 415 times

MEGNESIUM OXIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MASSAGE 2 0.2500
1 CHLAMYDIA IDENTIFICATION TEST POSITIVE 1 0.1250
2 EVENTRATION REPAIR 1 0.1111
3 ABSCESS MANAGEMENT 1 0.0455
4 SQUAMOUS CELL CARCINOMA OF THE HYPOPHARYNX 1 0.0312
5 UTERINE DILATION AND EVACUATION 1 0.0312
6 BENIGN SOFT TISSUE NEOPLASM 1 0.0263
7 GASTROINTESTINAL AMYLOIDOSIS 2 0.0241
8 RENAL LYMPHOCELE 1 0.0217
9 PROSTATITIS ESCHERICHIA COLI 1 0.0200
10 SUBDURAL EMPYEMA 1 0.0185
11 JUVENILE MYOCLONIC EPILEPSY 1 0.0159
12 PNEUMOCYSTIS TEST POSITIVE 1 0.0139
13 URINARY TRACT OPERATION 1 0.0120
14 HYPOPHARYNGEAL CANCER 1 0.0119
15 ISCHAEMIC SKIN ULCER 1 0.0108
16 ELECTROCARDIOGRAM U-WAVE ABNORMALITY 1 0.0102
17 BACTERIAL PROSTATITIS 1 0.0101
18 ANTICOAGULATION DRUG LEVEL INCREASED 3 0.0093
19 MELANOSIS COLI 1 0.0086
20 UTERINE ATONY 2 0.0076
21 IIIRD NERVE DISORDER 1 0.0070
22 LUNG SQUAMOUS CELL CARCINOMA STAGE UNSPECIFIED 1 0.0056
23 ACUTE PROMYELOCYTIC LEUKAEMIA DIFFERENTIATION SYNDROME 1 0.0048
24 PERIRENAL HAEMATOMA 1 0.0046
25 MILLER FISHER SYNDROME 1 0.0045
26 INTUBATION 1 0.0040
27 INTESTINAL ANASTOMOSIS COMPLICATION 1 0.0037
28 PROSTATIC ABSCESS 1 0.0036
29 PNEUMOCYSTIS JIROVECI INFECTION 1 0.0036
30 COLONIC PSEUDO-OBSTRUCTION 1 0.0036
31 LIVER TENDERNESS 1 0.0036
32 CATHETER SITE HAEMATOMA 1 0.0034
33 PLASMA CELL LEUKAEMIA 2 0.0033
34 ENTEROBACTER BACTERAEMIA 1 0.0033
35 PROTHROMBIN TIME RATIO DECREASED 2 0.0032
36 CARBON DIOXIDE ABNORMAL 1 0.0032
37 URINE CALCIUM INCREASED 1 0.0032
38 ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL 1 0.0031
39 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 1 0.0030
40 GLASGOW COMA SCALE ABNORMAL 1 0.0028
41 SMALL CELL LUNG CANCER STAGE UNSPECIFIED 1 0.0027
42 PNEUMOCYSTIS JIROVECII INFECTION 3 0.0025
43 VASCULAR STENT OCCLUSION 1 0.0025
44 LICHENIFICATION 1 0.0024
45 MYCOSIS FUNGOIDES 2 0.0024
46 AUTOIMMUNE THROMBOCYTOPENIA 1 0.0023
47 NITRITE URINE PRESENT 1 0.0023
48 CARDIAC OUTPUT DECREASED 2 0.0023
49 PRURIGO 2 0.0022
50 BILIARY SEPSIS 1 0.0022
51 ECZEMA ASTEATOTIC 1 0.0021
52 AMNESTIC DISORDER 1 0.0021
53 ENTEROCOLITIS HAEMORRHAGIC 3 0.0020
54 HYPERCREATININAEMIA 1 0.0020
55 PO2 INCREASED 1 0.0020
56 RENAL HAEMATOMA 1 0.0019
57 CRYPTOSPORIDIOSIS INFECTION 1 0.0019
58 NEUTROPHIL PERCENTAGE DECREASED 1 0.0019
59 SCROTAL PAIN 1 0.0019
60 CARDIAC AMYLOIDOSIS 2 0.0018
61 QUADRIPARESIS 3 0.0018
62 INTRAVASCULAR HAEMOLYSIS 1 0.0018
63 LICHENOID KERATOSIS 4 0.0017
64 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 1 0.0017
65 GINGIVAL HYPERPLASIA 1 0.0017
66 EXCORIATION 4 0.0016
67 POSTPARTUM HAEMORRHAGE 2 0.0015
68 PROTHROMBIN TIME ABNORMAL 1 0.0014
69 LIVEDO RETICULARIS 3 0.0014
70 MIXED LIVER INJURY 4 0.0013
71 CHOLANGITIS ACUTE 1 0.0013
72 FLAT AFFECT 3 0.0013
73 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 1 0.0013
74 OPHTHALMOPLEGIA 2 0.0013
75 SPUTUM CULTURE POSITIVE 1 0.0012
76 DERMATITIS EXFOLIATIVE 6 0.0012
77 MACULOPATHY 4 0.0011
78 ANORGASMIA 3 0.0011
79 FIBROMA 1 0.0011
80 DISTURBANCE IN SEXUAL AROUSAL 1 0.0011
81 EXTENSOR PLANTAR RESPONSE 1 0.0011
82 HAEMOCHROMATOSIS 1 0.0011
83 SKIN TEST POSITIVE 1 0.0011
84 APPLICATION SITE DERMATITIS 1 0.0011
85 PROTHROMBIN LEVEL DECREASED 1 0.0011
86 TELANGIECTASIA 1 0.0010
87 PCO2 DECREASED 1 0.0010
88 DEVICE RELATED THROMBOSIS 1 0.0010
89 CREPITATIONS 3 0.0010
90 RENAL HAEMORRHAGE 2 0.0010
91 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
92 FEBRILE BONE MARROW APLASIA 4 0.0009
93 CEREBELLAR SYNDROME 2 0.0009
94 ACUTE PULMONARY OEDEMA 5 0.0009
95 CARBON DIOXIDE DECREASED 1 0.0009
96 EPIDIDYMITIS 1 0.0009
97 DILATATION ATRIAL 1 0.0009
98 HYPORESPONSIVE TO STIMULI 1 0.0009
99 HAEMATOMA MUSCLE 1 0.0008
100 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 1 0.0008
101 FEBRILE CONVULSION 1 0.0008
102 HYPOMAGNESAEMIA 11 0.0008
103 SUBCUTANEOUS HAEMATOMA 1 0.0008
104 ADENOCARCINOMA PANCREAS 1 0.0008
105 IATROGENIC INJURY 1 0.0008
106 SINUS ARRHYTHMIA 1 0.0008
107 HIRSUTISM 1 0.0008
108 CARBON DIOXIDE INCREASED 1 0.0007
109 HYPERKERATOSIS 4 0.0007
110 MACULE 2 0.0007
111 THERAPEUTIC PROCEDURE 1 0.0007
112 SINUS ARREST 1 0.0006
113 LYMPHOPENIA 9 0.0006
114 KIDNEY TRANSPLANT REJECTION 3 0.0006
115 VENTRICULAR HYPOKINESIA 2 0.0006
116 THROMBOTIC MICROANGIOPATHY 6 0.0006
117 CYTOLYTIC HEPATITIS 2 0.0006
118 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 3 0.0006
119 POLYARTHRITIS 3 0.0006
120 PANCREATIC FAILURE 1 0.0006
121 HEPATOCELLULAR INJURY 8 0.0006
122 RASH PUSTULAR 4 0.0005
123 AURA 1 0.0005
124 ADENOCARCINOMA OF COLON 1 0.0005
125 HYPOREFLEXIA 1 0.0005
126 ATRIAL FLUTTER 4 0.0005
127 CANDIDIASIS 2 0.0005
128 DIVERTICULAR PERFORATION 1 0.0005
129 MICROCYTIC ANAEMIA 1 0.0005
130 PETECHIAE 5 0.0005
131 HYPOCALCAEMIA 9 0.0005
132 CHOLESTASIS 9 0.0005
133 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
134 FACIAL PALSY 1 0.0005
135 DIABETIC NEPHROPATHY 1 0.0005
136 PARESIS 1 0.0004
137 DIVERTICULUM INTESTINAL HAEMORRHAGIC 1 0.0004
138 HAEMANGIOMA 1 0.0004
139 BILIRUBIN CONJUGATED INCREASED 1 0.0004
140 COLORECTAL CANCER METASTATIC 1 0.0004
141 HYPOVOLAEMIC SHOCK 2 0.0004
142 GRAFT VERSUS HOST DISEASE 3 0.0004
143 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
144 HYPERPARATHYROIDISM SECONDARY 1 0.0004
145 CORONARY ARTERY STENOSIS 2 0.0004
146 BLOOD CHLORIDE DECREASED 1 0.0004
147 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 3 0.0004
148 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
149 RADICULOPATHY 1 0.0004
150 LUNG OPACITY 1 0.0004
151 ANAL FISTULA 2 0.0004
152 STEATORRHOEA 1 0.0004
153 LARYNGOSPASM 1 0.0004
154 SHOCK HAEMORRHAGIC 3 0.0004
155 HYPOKALAEMIA 17 0.0004
156 MIGRAINE WITH AURA 1 0.0004
157 SUBDURAL HAEMORRHAGE 1 0.0004
158 LUNG CONSOLIDATION 1 0.0004
159 PSYCHOMOTOR RETARDATION 1 0.0004
160 NEUTROPHIL COUNT ABNORMAL 1 0.0004
161 ACUTE LYMPHOCYTIC LEUKAEMIA 1 0.0004
162 MYOPATHY 3 0.0003
163 ESCHERICHIA SEPSIS 1 0.0003
164 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
165 LOSS OF LIBIDO 3 0.0003
166 REBOUND ACID HYPERSECRETION 1 0.0003
167 AGRANULOCYTOSIS 6 0.0003
168 ELECTROENCEPHALOGRAM ABNORMAL 1 0.0003
169 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
170 PNEUMONIA VIRAL 1 0.0003
171 RASH PAPULAR 7 0.0003
172 PROCTALGIA 2 0.0003
173 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1 0.0003
174 TOXIC SKIN ERUPTION 3 0.0003
175 CEREBRAL HAEMATOMA 1 0.0003
176 FACE OEDEMA 5 0.0003
177 BRONCHOPNEUMONIA 1 0.0003
178 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
179 EMBOLIC STROKE 1 0.0003
180 DEPRESSIVE SYMPTOM 1 0.0003
181 DUODENAL ULCER 2 0.0003
182 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
183 ISCHAEMIC STROKE 5 0.0003
184 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
185 MYELODYSPLASTIC SYNDROME 4 0.0003
186 BLOOD PHOSPHORUS DECREASED 1 0.0003
187 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0003
188 RASH MACULO-PAPULAR 6 0.0003
189 HAEMODYNAMIC INSTABILITY 2 0.0003
190 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
191 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
192 HYPOALBUMINAEMIA 2 0.0003
193 SPINAL CORD COMPRESSION 1 0.0003
194 TORSADE DE POINTES 2 0.0003
195 CEREBRAL ATROPHY 1 0.0003
196 AZOTAEMIA 1 0.0003
197 TRANSPLANT REJECTION 2 0.0002
198 BLEPHARITIS 1 0.0002
199 CYSTITIS HAEMORRHAGIC 1 0.0002
200 POLYURIA 2 0.0002
201 ACUTE CORONARY SYNDROME 2 0.0002
202 HEMIPLEGIA 2 0.0002
203 BUNDLE BRANCH BLOCK LEFT 1 0.0002
204 RENAL FAILURE ACUTE 10 0.0002
205 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
206 HEPATIC PAIN 1 0.0002
207 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
208 CARDIAC MURMUR 2 0.0002
209 EOSINOPHILIA 4 0.0002
210 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
211 DRUG ERUPTION 4 0.0002
212 WHEELCHAIR USER 1 0.0002
213 DRUG LEVEL ABOVE THERAPEUTIC 1 0.0002
214 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
215 NEPHROGENIC ANAEMIA 1 0.0002
216 PERFORMANCE STATUS DECREASED 1 0.0002
217 GUILLAIN-BARRE SYNDROME 1 0.0002
218 FLUID OVERLOAD 3 0.0002
219 THROMBOCYTOPENIA 23 0.0002
220 RENAL TUBULAR NECROSIS 2 0.0002
221 RASH PRURITIC 11 0.0002
222 HYPERNATRAEMIA 1 0.0002
223 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1 0.0002
224 ENDOCARDITIS 1 0.0002
225 SKIN NECROSIS 1 0.0002
226 FAILURE TO THRIVE 1 0.0002
227 PARTIAL SEIZURES 1 0.0002
228 SERUM FERRITIN INCREASED 1 0.0002
229 JAW DISORDER 1 0.0002
230 GASTRIC ULCER HAEMORRHAGE 1 0.0002
231 MITRAL VALVE INCOMPETENCE 2 0.0002
232 HYPERTONIA 1 0.0002
233 ELECTROLYTE IMBALANCE 2 0.0002
234 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
235 HYPERTRIGLYCERIDAEMIA 1 0.0002
236 NEUTROPENIA 23 0.0002
237 RESPIRATORY DISORDER 5 0.0002
238 HEPATITIS CHOLESTATIC 1 0.0002
239 GANGRENE 1 0.0002
240 NO THERAPEUTIC RESPONSE 2 0.0002
241 EPILEPSY 5 0.0002
242 CYTOPENIA 2 0.0002
243 CARDIOMEGALY 2 0.0002
244 LARYNGEAL OEDEMA 1 0.0002
245 HYPERCALCAEMIA 2 0.0002
246 CHOLANGITIS 1 0.0002
247 TOOTH EXTRACTION 2 0.0002
248 SCREAMING 1 0.0002
249 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
250 HYPOGAMMAGLOBULINAEMIA 1 0.0002
251 DYSGRAPHIA 1 0.0002
252 PRODUCT FORMULATION ISSUE 1 0.0002
253 SOPOR 2 0.0002
254 URINARY RETENTION 5 0.0001
255 BONE MARROW FAILURE 3 0.0001
256 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
257 PERITONITIS 3 0.0001
258 LARGE INTESTINE PERFORATION 1 0.0001
259 AUTOIMMUNE HEPATITIS 1 0.0001
260 FORMICATION 1 0.0001
261 LYMPHADENOPATHY 5 0.0001
262 ANGINA PECTORIS 4 0.0001
263 CARDIOGENIC SHOCK 2 0.0001
264 HYPERTHYROIDISM 2 0.0001
265 INTENTIONAL UNDERDOSE 1 0.0001
266 MOUTH HAEMORRHAGE 1 0.0001
267 MELAENA 3 0.0001
268 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
269 FEELING DRUNK 1 0.0001
270 PANCREATITIS ACUTE 3 0.0001
271 DYSARTHRIA 5 0.0001
272 HEPATIC FAILURE 4 0.0001
273 RENAL FAILURE CHRONIC 1 0.0001
274 HAEMOLYSIS 1 0.0001
275 ATRIOVENTRICULAR BLOCK 1 0.0001
276 ACUTE MYELOID LEUKAEMIA 2 0.0001
277 NERVOUS SYSTEM DISORDER 4 0.0001
278 HAEMORRHAGIC STROKE 1 0.0001
279 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
280 BLOOD DISORDER 1 0.0001
281 RHINITIS 1 0.0001
282 MENTAL IMPAIRMENT 3 0.0001
283 ENCEPHALOPATHY 3 0.0001
284 HICCUPS 1 0.0001
285 HAIR DISORDER 1 0.0001
286 VENTRICULAR TACHYCARDIA 2 0.0001
287 SPINAL COMPRESSION FRACTURE 1 0.0001
288 FEBRILE NEUTROPENIA 8 0.0001
289 VISUAL ACUITY REDUCED 4 0.0001
290 SECOND PRIMARY MALIGNANCY 1 0.0001
291 HAEMODIALYSIS 1 0.0001
292 HEMIPARESIS 2 0.0001
293 ACUTE KIDNEY INJURY 18 0.0001
294 FACIAL PARALYSIS 1 0.0001
295 VITAMIN D DECREASED 1 0.0001
296 ANURIA 1 0.0001
297 PYELONEPHRITIS 1 0.0001
298 ANHEDONIA 3 0.0001
299 GASTROINTESTINAL INFECTION 1 0.0001
300 END STAGE RENAL DISEASE 2 0.0001
301 UROSEPSIS 1 0.0001
302 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
303 HEPATIC STEATOSIS 2 0.0001
304 PANCYTOPENIA 6 0.0001
305 HEPATIC ENCEPHALOPATHY 1 0.0001
306 OEDEMA PERIPHERAL 13 0.0001
307 SQUAMOUS CELL CARCINOMA 1 0.0001
308 PROTEINURIA 2 0.0001
309 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
310 PRESCRIBED OVERDOSE 2 0.0001
311 INTERSTITIAL LUNG DISEASE 5 0.0001
312 ASCITES 3 0.0001
313 HEPATOMEGALY 1 0.0001
314 HYPOTONIA 1 0.0001
315 SUBARACHNOID HAEMORRHAGE 1 0.0001
316 HYPERBILIRUBINAEMIA 1 0.0001
317 INTENTIONAL DRUG MISUSE 2 0.0001
318 TRANSFUSION 1 0.0001
319 FOLLICULITIS 1 0.0001
320 HALLUCINATION, VISUAL 2 0.0001
321 FULL BLOOD COUNT ABNORMAL 1 0.0001
322 OSTEONECROSIS 3 0.0001
323 RENAL FAILURE 12 0.0001
324 TOOTH DISORDER 2 0.0001
325 MALNUTRITION 1 0.0001
326 BLOOD CALCIUM DECREASED 1 0.0001
327 MYOCARDITIS 1 0.0001
328 MADAROSIS 1 0.0001
329 POST PROCEDURAL HAEMORRHAGE 1 0.0001
330 VASCULITIS 1 0.0001
331 SPLENOMEGALY 1 0.0001
332 BLOOD IRON DECREASED 1 0.0001
333 CHOLECYSTITIS 1 0.0001
334 POLYNEUROPATHY 1 0.0001
335 C-REACTIVE PROTEIN INCREASED 3 0.0001
336 PRESYNCOPE 2 0.0001
337 ATRIAL FIBRILLATION 8 0.0001
338 DRUG INTERACTION 13 0.0001
339 LUNG DISORDER 4 0.0001
340 RESPIRATORY DEPRESSION 1 0.0001
341 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
342 OSTEONECROSIS OF JAW 2 0.0001
343 PHARYNGITIS 1 0.0001
344 HAIR COLOUR CHANGES 1 0.0001
345 LEUKOPENIA 4 0.0001
346 SKIN ULCER 2 0.0001
347 RASH GENERALISED 2 0.0001
348 HAEMATOMA 2 0.0001
349 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
350 ORAL CANDIDIASIS 1 0.0001
351 PYREXIA 26 0.0001
352 HAIR TEXTURE ABNORMAL 1 0.0001
353 PRODUCT TASTE ABNORMAL 1 0.0001
354 RESPIRATORY ARREST 2 0.0001
355 RHABDOMYOLYSIS 3 0.0001
356 RENAL IMPAIRMENT 6 0.0001
357 DEVICE OCCLUSION 1 0.0001
358 HYPONATRAEMIA 4 0.0001
359 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
360 RECTAL HAEMORRHAGE 3 0.0001
361 HYPERSOMNIA 2 0.0001
362 HYPOKINESIA 1 0.0001
363 BLOOD POTASSIUM DECREASED 2 0.0001
364 APHASIA 2 0.0001
365 BLOOD COUNT ABNORMAL 1 0.0001
366 PLEURAL EFFUSION 4 0.0001
367 INSURANCE ISSUE 1 0.0001
368 THYROID DISORDER 1 0.0001
369 LYMPHOMA 1 0.0001
370 ANKLE FRACTURE 1 0.0001
371 LUNG INFECTION 1 0.0001
372 EJECTION FRACTION DECREASED 1 0.0001
373 PRODUCT USE COMPLAINT 1 0.0001
374 PNEUMOTHORAX 1 0.0001
375 RASH ERYTHEMATOUS 3 0.0001
376 HIP FRACTURE 2 0.0001
377 MUSCLE TIGHTNESS 1 0.0001
378 BLOOD CREATININE INCREASED 4 0.0001
379 CARDIAC ARREST 5 0.0001
380 CYTOMEGALOVIRUS INFECTION 1 0.0001
381 SKIN DISORDER 2 0.0001
382 BLOOD UREA INCREASED 1 0.0001
383 METRORRHAGIA 1 0.0001
384 HAEMOGLOBIN DECREASED 6 0.0001
385 ANAEMIA 11 0.0001
386 DELIRIUM 2 0.0001
387 NEUROTOXICITY 1 0.0001
388 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
389 TACHYCARDIA 5 0.0001
390 GOUT 1 0.0001
391 LEUKOCYTOSIS 1 0.0001
392 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
393 AGITATION 4 0.0001
394 BRONCHITIS 4 0.0001
395 SEPSIS 6 0.0001
396 OXYGEN SATURATION DECREASED 3 0.0001
397 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
398 HEPATIC CIRRHOSIS 1 0.0001
399 GASTRIC ULCER 1 0.0001
400 POST PROCEDURAL COMPLICATION 1 0.0001
401 LOWER LIMB FRACTURE 1 0.0001
402 ACUTE RESPIRATORY FAILURE 1 0.0001
403 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
404 ABNORMAL BEHAVIOUR 2 0.0001
405 FULL BLOOD COUNT DECREASED 1 0.0000
406 INFECTION 7 0.0000
407 WITHDRAWAL SYNDROME 2 0.0000
408 EATING DISORDER 1 0.0000
409 IMPAIRED WORK ABILITY 1 0.0000
410 CONSTIPATION 10 0.0000
411 BLOOD PRESSURE DECREASED 3 0.0000
412 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
413 STEVENS-JOHNSON SYNDROME 1 0.0000
414 PULMONARY OEDEMA 2 0.0000
415 ORAL PAIN 1 0.0000
416 PERICARDIAL EFFUSION 1 0.0000
417 COGNITIVE DISORDER 2 0.0000
418 BURNING SENSATION 3 0.0000
419 OVERDOSE 9 0.0000
420 URINARY TRACT INFECTION 7 0.0000
421 HYPOTENSION 8 0.0000
422 ACNE 3 0.0000
423 CHRONIC KIDNEY DISEASE 3 0.0000
424 FLUID RETENTION 2 0.0000
425 HEPATITIS 1 0.0000
426 DRUG RESISTANCE 1 0.0000
427 ERYTHEMA 8 0.0000
428 ANAPHYLACTIC SHOCK 1 0.0000
429 VOMITING 18 0.0000
430 ECZEMA 2 0.0000
431 MUCOSAL INFLAMMATION 1 0.0000
432 PANCREATITIS 2 0.0000
433 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
434 PLATELET COUNT DECREASED 4 0.0000
435 CARDIAC FAILURE CONGESTIVE 3 0.0000
436 BLOOD BILIRUBIN INCREASED 1 0.0000
437 THROAT TIGHTNESS 1 0.0000
438 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
439 PNEUMONITIS 1 0.0000
440 ABNORMAL DREAMS 1 0.0000
441 FEELING COLD 1 0.0000
442 DIARRHOEA 23 0.0000
443 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
444 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
445 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
446 RED BLOOD CELL COUNT DECREASED 1 0.0000
447 CONVULSION 2 0.0000
448 BALANCE DISORDER 3 0.0000
449 BONE PAIN 2 0.0000
450 VERTIGO 2 0.0000
451 DRUG ADMINISTRATION ERROR 1 0.0000
452 LIMB DISCOMFORT 1 0.0000
453 ASTHENIA 12 0.0000
454 NEUROPATHY PERIPHERAL 3 0.0000
455 MOVEMENT DISORDER 1 0.0000
456 NIGHT SWEATS 1 0.0000
457 CONFUSIONAL STATE 5 0.0000
458 CHOLELITHIASIS 1 0.0000
459 EYE DISORDER 1 0.0000
460 INFUSION RELATED REACTION 2 0.0000
461 VIRAL INFECTION 1 0.0000
462 DEHYDRATION 4 0.0000
463 SYNCOPE 3 0.0000
464 TYPE 2 DIABETES MELLITUS 1 0.0000
465 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
466 ANGER 1 0.0000
467 NIGHTMARE 1 0.0000
468 HYPERKALAEMIA 1 0.0000
469 HEART RATE DECREASED 1 0.0000
470 HYPOXIA 1 0.0000
471 SLEEP DISORDER 2 0.0000
472 HYPERTENSION 6 0.0000
473 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
474 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
475 PANIC ATTACK 1 0.0000
476 ACCIDENTAL OVERDOSE 1 0.0000
477 DYSURIA 1 0.0000
478 INFLUENZA 3 0.0000
479 EPISTAXIS 2 0.0000
480 COLITIS 1 0.0000
481 DECREASED APPETITE 6 0.0000
482 PALPITATIONS 3 0.0000
483 CHILLS 3 0.0000
484 DISEASE PROGRESSION 3 0.0000
485 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
486 DISORIENTATION 1 0.0000
487 CARDIAC FAILURE 2 0.0000
488 DYSPNOEA 14 0.0000
489 DYSKINESIA 1 0.0000
490 NEUTROPHIL COUNT DECREASED 1 0.0000
491 INFLUENZA LIKE ILLNESS 2 0.0000
492 ABDOMINAL PAIN UPPER 5 0.0000
493 POLLAKIURIA 1 0.0000
494 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
495 CARDIO-RESPIRATORY ARREST 1 0.0000
496 SEPTIC SHOCK 1 0.0000
497 LIVER DISORDER 1 0.0000
498 COLITIS ULCERATIVE 1 0.0000
499 WEIGHT INCREASED 5 0.0000
500 THROAT IRRITATION 1 0.0000
501 MEMORY IMPAIRMENT 3 0.0000
502 NEPHROLITHIASIS 1 0.0000
503 MUSCLE SPASMS 4 0.0000
504 PNEUMONIA 7 0.0000
505 BLOOD CHOLESTEROL INCREASED 1 0.0000
506 COMA 1 0.0000
507 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
508 CONTUSION 2 0.0000
509 HYPOGLYCAEMIA 1 0.0000
510 ALOPECIA 4 0.0000
511 DYSPEPSIA 2 0.0000
512 FLUSHING 2 0.0000
513 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
514 INFLAMMATION 1 0.0000
515 MUSCULOSKELETAL PAIN 1 0.0000
516 SPEECH DISORDER 1 0.0000
517 DEPRESSED MOOD 1 0.0000
518 BRADYCARDIA 1 0.0000
519 DISTURBANCE IN ATTENTION 1 0.0000
520 OEDEMA 1 0.0000
521 TREATMENT NONCOMPLIANCE 1 0.0000
522 PRURITUS 7 0.0000
523 TREMOR 3 0.0000
524 FALL 6 0.0000
525 MEDICATION ERROR 1 0.0000
526 COUGH 5 0.0000
527 MYALGIA 3 0.0000
528 FLATULENCE 1 0.0000
529 MUSCULAR WEAKNESS 2 0.0000
530 PRODUCT SUBSTITUTION ISSUE 1 0.0000
531 ABDOMINAL PAIN 4 0.0000
532 DYSPHONIA 1 0.0000
533 SURGERY 1 0.0000
534 NASAL CONGESTION 1 0.0000
535 CATARACT 1 0.0000
536 IRRITABILITY 1 0.0000
537 CONDITION AGGRAVATED 5 0.0000
538 VISUAL IMPAIRMENT 2 0.0000
539 RASH 7 0.0000
540 FATIGUE 12 0.0000
541 NAUSEA 12 0.0000
542 DRY SKIN 2 0.0000
543 NEOPLASM MALIGNANT 1 0.0000
544 HEPATIC ENZYME INCREASED 1 0.0000
545 WEIGHT DECREASED 4 0.0000
546 THERAPY INTERRUPTED 1 0.0000
547 SKIN BURNING SENSATION 1 0.0000
548 MOBILITY DECREASED 1 0.0000
549 UNDERDOSE 1 0.0000
550 DYSGEUSIA 1 0.0000
551 HALLUCINATION 1 0.0000
552 PAIN 8 0.0000
553 BACK PAIN 3 0.0000
554 ARTHRITIS 1 0.0000
555 PARAESTHESIA 2 0.0000
556 DRUG ABUSE 1 0.0000
557 ABDOMINAL DISCOMFORT 2 0.0000
558 TOXICITY TO VARIOUS AGENTS 2 0.0000
559 SKIN EXFOLIATION 1 0.0000
560 CEREBROVASCULAR ACCIDENT 2 0.0000
561 MYOCARDIAL INFARCTION 2 0.0000
562 INTENTIONAL PRODUCT MISUSE 1 0.0000
563 DRUG WITHDRAWAL SYNDROME 1 0.0000
564 HEADACHE 7 0.0000
565 GASTROINTESTINAL DISORDER 1 0.0000
566 NO ADVERSE EVENT 2 0.0000
567 ADVERSE EVENT 1 0.0000
568 NASOPHARYNGITIS 2 0.0000
569 CHEST PAIN 2 0.0000
570 CARDIAC DISORDER 1 0.0000
571 SWELLING 1 0.0000
572 DYSPHAGIA 1 0.0000
573 GAIT DISTURBANCE 2 0.0000
574 DIZZINESS 5 0.0000
575 SOMNOLENCE 2 0.0000
576 CHEST DISCOMFORT 1 0.0000
577 SINUSITIS 1 0.0000
578 ILLNESS 1 0.0000
579 ABDOMINAL DISTENSION 1 0.0000
580 OFF LABEL USE 8 0.0000
581 MALAISE 4 0.0000
582 RHEUMATOID ARTHRITIS 1 0.0000
583 DEPRESSION 2 0.0000
584 INCORRECT DOSE ADMINISTERED 2 0.0000
585 JOINT SWELLING 1 0.0000
586 LOSS OF CONSCIOUSNESS 1 0.0000
587 HYPERHIDROSIS 1 0.0000
588 PSORIASIS 1 0.0000
589 INSOMNIA 2 0.0000
590 ANXIETY 2 0.0000
591 PRODUCT DOSE OMISSION ISSUE 2 0.0000
592 BLOOD PRESSURE INCREASED 1 0.0000
593 DRUG DEPENDENCE 1 0.0000
594 DRUG DOSE OMISSION 1 0.0000
595 URTICARIA 1 0.0000
596 HYPERSENSITIVITY 1 0.0000
597 PRODUCT USE ISSUE 1 0.0000
598 DRUG INEFFECTIVE 7 0.0000
599 BLOOD GLUCOSE INCREASED 1 0.0000
600 ARTHRALGIA 2 0.0000
601 PAIN IN EXTREMITY 1 0.0000
602 INJECTION SITE PAIN 1 0.0000
603 DEATH 2 0.0000